Vaccine News and Research

Latest Vaccine News and Research

Delta variant has a more diverse repertoire of mutations than other variants

In a paper, nearly 2 million SARS-CoV-2 genomes from around the world were analyzed, finding great diversity within the delta variant that exceeds that observed in the more widely spread alpha variant.

6 Sep 2021

Decreased COVID-19 vaccine efficacy amongst IBS patients receiving anti-TNFα drugs

In a paper recently uploaded to the preprint server medRxiv* by Edelman-Klapper et al., the efficacy of the mRNA vaccine is examined amongst IBD patients and compared with healthy volunteers, finding reduced efficacy amongst those receiving anti-TNFα medication.

6 Sep 2021

mRNA COVID-19 vaccine protection wanes after six months: a wide-scale study of the population of Qatar

In a paper recently uploaded to the preprint server medRxiv* by Chemaitelly et al. (August 27, 2021), the long-term effectiveness of the mRNA vaccines is analyzed amongst the Qatar population. The study observed waning protection against infection around six months post-vaccination but lasting protection from death and hospitalization.

6 Sep 2021

Reduction in infectious SARS-CoV-2 shedding in vaccine breakthrough infections

In a paper recently uploaded to the preprint server medRxiv*, breakthrough infections are compared with infections in immunologically naïve individuals

6 Sep 2021

Is the SARS-CoV-2 Lambda variant more vaccine-resistant than the Delta variant?

Researchers in the USA and China recently published a report in which they discussed the potential factors that confer high infectivity and immune resistance on the Delta and Lambda variants.

6 Sep 2021

Israeli study on viral load, Delta infections, vaccinations and boosters

Scientists from Israel have recently explored the effectiveness of two-dose and three-dose regimens of the BNT162b2 coronavirus disease 2019 (COVID-19) vaccine (Pfizer/BioNTech) to reduce viral load in breakthrough infections caused by the delta variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

6 Sep 2021

Post-exposure prophylaxis with monoclonal antibodies may reduce health system burden in the US

In a study conducted at the University of Washington, USA, the researchers assert that post-exposure prophylaxis with monoclonal antibodies could improve the clinical outcomes and health system costs regarding coronavirus disease (COVID-19). The study is currently available on the medRxiv* preprint server.

6 Sep 2021

Study finds a restricted number of possible escape mutations for SARS-CoV-2 Delta variant

The emergence of escape mutations in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is somewhat less likely for the Delta variant in comparison with the original or wild type virus, shows a recent study currently available on the bioRxiv* preprint server while it undergoes peer review.

5 Sep 2021

Health Secretary urges G20 countries to recognize UK's COVID-19 vaccine clinical trial participants

The rights of vaccine clinical trial volunteers must be safeguarded to help protect everyone against future health crises, Health and Social Care Secretary Sajid Javid will tell G20 health leaders in Rome today (Sunday 5 September).

5 Sep 2021

Efficacy of vaccines against the SARS-CoV-2 Delta variant

A new study uses statistical models to determine vaccine efficacy against the various SARS-CoV-2 variants and clinical endpoints for SARS-CoV-2 variants.

5 Sep 2021

Researchers find no serious health effects linked to mRNA COVID-19 vaccines

Federal and Kaiser Permanente researchers combing the health records of 6.2 million patients found no serious health effects that could be linked to the 2 mRNA COVID-19 vaccines.

4 Sep 2021

Chief medical officers to consider vaccination of 12 to 15 year olds from a broader perspective

The four Chief Medical Officers will provide further advice on the COVID-19 vaccination of young people aged 12 to 15 with COVID-19 vaccines following the advice of the independent Joint Committee on Vaccination and Immunisation.

4 Sep 2021

New diagnostic system can rapidly and sensitively measure antibodies against SARS-CoV-2

A research team at the RIKEN Center for Emergent Matter Science in Japan has developed a diagnostic system that can rapidly and sensitively measure the amount of antibodies in the blood that can protect us from SARS-CoV-2, the virus that causes COVID-19.

4 Sep 2021

Weill Cornell receives NIH support to advance TB research

Tuberculosis (TB) is one of the deadliest infectious diseases in history and one of the few that naturally infects only humans.

4 Sep 2021

HIV vaccine candidate trialed in Sub-Saharan Africa falls short

An HIV vaccine candidate trialed in Sub-Saharan Africa offers no substantial protection against HIV infection among young women, the study organizers say.

4 Sep 2021

Immunological differences in Moderna and Pfizer-BioNTech vaccine-induced Fc-functional profiles

A new study analyzed the post-boost binding and functional capacity of the humoral response induced by the Pfizer-BioNTech and Moderna vaccines.

3 Sep 2021

Income, race, and ethnical-mediated inequities in COVID-19 vaccination across major US cities

Differences in vaccination rates across the 9 biggest US cities associated with race, ethnicity, and income levels.

3 Sep 2021

Can COVID-19 vaccines affect athletic performance in the short term?

Getting the COVID-19 vaccine — especially the second shot — can produce minor side effects such as aches and fever that tend to go away after a day or two. Adding to the list, a small study from the University of Arizona found that people may find it slightly challenging to exercise after getting a two-dose coronavirus vaccine.

3 Sep 2021

Third vaccine dose reduces transmission and severe COVID-19 nationwide in Israel

A new preprint investigates the efficacy of a booster vaccine on a nationwide scale in reducing viral spread and the number of severe COVID-19 cases.

3 Sep 2021

Antibody cocktail neutralizes SARS-CoV-2 and has projected protection up to 12 months

A new study reports long-lasting, effective protection against severe disease with the AZD7442 antibody cocktail.

3 Sep 2021

Vaccine News and Research

Latest Vaccine News and Research

Delta variant has a more diverse repertoire of mutations than other variants

Decreased COVID-19 vaccine efficacy amongst IBS patients receiving anti-TNFα drugs

mRNA COVID-19 vaccine protection wanes after six months: a wide-scale study of the population of Qatar

Reduction in infectious SARS-CoV-2 shedding in vaccine breakthrough infections

Is the SARS-CoV-2 Lambda variant more vaccine-resistant than the Delta variant?

Israeli study on viral load, Delta infections, vaccinations and boosters

Post-exposure prophylaxis with monoclonal antibodies may reduce health system burden in the US

Study finds a restricted number of possible escape mutations for SARS-CoV-2 Delta variant

Health Secretary urges G20 countries to recognize UK's COVID-19 vaccine clinical trial participants

Efficacy of vaccines against the SARS-CoV-2 Delta variant

Researchers find no serious health effects linked to mRNA COVID-19 vaccines

Chief medical officers to consider vaccination of 12 to 15 year olds from a broader perspective

New diagnostic system can rapidly and sensitively measure antibodies against SARS-CoV-2

Weill Cornell receives NIH support to advance TB research

HIV vaccine candidate trialed in Sub-Saharan Africa falls short

Immunological differences in Moderna and Pfizer-BioNTech vaccine-induced Fc-functional profiles

Income, race, and ethnical-mediated inequities in COVID-19 vaccination across major US cities

Can COVID-19 vaccines affect athletic performance in the short term?

Third vaccine dose reduces transmission and severe COVID-19 nationwide in Israel

Antibody cocktail neutralizes SARS-CoV-2 and has projected protection up to 12 months

eBook: Advancing infectious disease vaccine development eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Vaccine News and Research

Latest Vaccine News and Research

eBook: Advancing infectious disease vaccine development eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Newsletters you may be interested in